Price in deferred time of 15 minutes
Last quote
10/23/2024 -
16:15:00
|
Bid
10/23/2024 -
16:00:00
|
Bid Volume |
Ask
10/23/2024 -
16:00:00
|
Ask Volume |
---|---|---|---|---|
2.69
-0.13
(
-4.61% )
|
2.69
|
46,100 |
2.70
|
33,900 |
Analysis date: 18.10.2024
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 11.10.2024.
Interest
Very weak
Very weak
Very weak interest since 04.10.2024.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 04.10.2024 at a price of 3.21.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 06.08.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is .
4wk Rel Perf
-29.70%
-29.70%
The four week relative underperformance versus SP500 is 29.70%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 03.11.2023.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.63%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 7.24%.
Mkt Cap in $bn
1.23
1.23
With a market capitalization <$2bn, AGILON HEALTH is considered a small-cap stock.
G/PE Ratio
0.05
0.05
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-47.44
-47.44
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
2.46%
2.46%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-25
-25
For 1% of index variation, the stock varies on average by -0.25%.
Correlation
0.02
0.02
Stock movements are totally independent of index variations.
Value at Risk
1.21
1.21
The value at risk is estimated at USD 1.21. The risk is therefore 40.74%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.10.2021
26.10.2021